Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 13, 2020 16:02 ET | Source: Equillium

Equillium Announces Proposed Public Offering of Common Stock

LA JOLLA, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders,...
August 12, 2020 08:37 ET | Source: Equillium

Equillium Reports Second Quarter 2020 Financial Results and Recent Highlights

LA JOLLA, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders,...
August 10, 2020 16:07 ET | Source: Equillium

Equillium Announces Positive Interim Data with Itolizumab in Acute GVHD Study

Complete response observed in five of seven patients in first two dose cohorts COVID-19 Pre-IND meeting request and briefing package submitted to the FDA LA JOLLA, Calif., Aug. 10, 2020 (GLOBE...
July 30, 2020 16:07 ET | Source: Equillium

Equillium to Present at BTIG Virtual Biotechnology Conference 2020

LA JOLLA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to...
July 13, 2020 03:30 ET | Source: Equillium

Clinical Trial Shows Itolizumab Reduces Mortality in Patients Hospitalized with COVID-19

Equillium shares topline results of patients treated with itolizumab in clinical trial conducted in India by partner Biocon Biocon has received emergency use approval from Drugs Controller General of...
May 21, 2020 16:07 ET | Source: Equillium

Equillium to Present at Jefferies Virtual Healthcare Conference

LA JOLLA, Calif., May 21, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to...
May 13, 2020 16:07 ET | Source: Equillium

Equillium Reports First Quarter 2020 Financial Results

LA JOLLA, Calif., May 13, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat...
May 07, 2020 16:07 ET | Source: Equillium

Equillium to Present at 2020 RBC Capital Markets Virtual Global Healthcare Conference

LA JOLLA, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to...
March 30, 2020 16:07 ET | Source: Equillium

Equillium Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital

LA JOLLA, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat...
March 26, 2020 16:07 ET | Source: Equillium

Equillium Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update

EQUIP and EQUALISE Studies to be Paused in Response to the COVID-19 Pandemic Company Reaffirms Guidance to Report Initial Data from the EQUATE Trial in Acute GVHD in 2H 2020 LA JOLLA, Calif., March ...